In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other therapeutics represents one of the most consequential regulatory developments in ...

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced an ambitious effort to modernize drug testing by reducing reliance on animal models in favor of advanced, human-relevant ...

As a researcher, I still remember the discomfort I felt every time I had to sacrifice laboratory animals for an experiment. For decades, animals like mice, rats and pigs have been essential tools in ...

For generations, U.S. laboratories treated animal testing as an unquestioned prerequisite for new drugs and chemicals, even as the ethical toll mounted. Now, after centuries of routine cruelty, the ...

Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests ...

Experiments on animals (“in vivo” experiments) have long been the norm for learning about human health and disease, because testing on live animals enables researchers to investigate how chemicals, ...

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...

Criticism of animal research − usually associated with the progressive left − has grown in recent years, as the practice is blamed for the slow pace of drug development. The Food and Drug ...

This is read by an automated voice. Please report any issues or inconsistencies here. I am living with ALS, or amyotrophic lateral sclerosis, often called Lou Gehrig’s disease. The average survival ...